Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Diamond

Showing results (981-990 of 1,007) with videos related to

Pageof 101
Sort By:
Nature|July 16, 2020
Potently neutralizing and protective human antibodies against SARS-CoV-2Seth J Zost, Pavlo Gilchuk, James Brett Case, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model SeraBarbara Mühlemann, Samuel H Wilks, Lauren Baracco, et al.
Nature|May 16, 2022
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2Ryuta Uraki, Maki Kiso, Shun Iida, et al.
Science Translational Medicine|May 15, 2024
Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assaysBarbara Mühlemann, Samuel H Wilks, Lauren Baracco, et al.
Immunity|May 28, 2021
SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2Qiao Lu, Jia Liu, Shuai Zhao, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2021
Multivalent designed proteins protect against SARS-CoV-2 variants of concernAndrew C Hunt, James Brett Case, Young-Jun Park, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2022
Computationally restoring the potency of a clinical antibody against SARS-CoV-2 Omicron subvariantsThomas A Desautels, Kathryn T Arrildt, Adam T Zemla, et al.
Nature|May 8, 2024
Computationally restoring the potency of a clinical antibody against OmicronThomas A Desautels, Kathryn T Arrildt, Adam T Zemla, et al.
Biorxiv : the Preprint Server for Biology|November 21, 2023
Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman PrimatesMatthew Gagne, Barbara J Flynn, Shayne F Andrew, et al.
Nature Immunology|September 3, 2024
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primatesMatthew Gagne, Barbara J Flynn, Shayne F Andrew, et al.
Pageof 101

Showing results (981-990 of 1,007) with videos related to

Sort By:
Pageof 101
Nature|July 16, 2020
Potently neutralizing and protective human antibodies against SARS-CoV-2Seth J Zost, Pavlo Gilchuk, James Brett Case, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model SeraBarbara Mühlemann, Samuel H Wilks, Lauren Baracco, et al.
Nature|May 16, 2022
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2Ryuta Uraki, Maki Kiso, Shun Iida, et al.
Science Translational Medicine|May 15, 2024
Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assaysBarbara Mühlemann, Samuel H Wilks, Lauren Baracco, et al.
Immunity|May 28, 2021
SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2Qiao Lu, Jia Liu, Shuai Zhao, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2021
Multivalent designed proteins protect against SARS-CoV-2 variants of concernAndrew C Hunt, James Brett Case, Young-Jun Park, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2022
Computationally restoring the potency of a clinical antibody against SARS-CoV-2 Omicron subvariantsThomas A Desautels, Kathryn T Arrildt, Adam T Zemla, et al.
Nature|May 8, 2024
Computationally restoring the potency of a clinical antibody against OmicronThomas A Desautels, Kathryn T Arrildt, Adam T Zemla, et al.
Biorxiv : the Preprint Server for Biology|November 21, 2023
Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman PrimatesMatthew Gagne, Barbara J Flynn, Shayne F Andrew, et al.
Nature Immunology|September 3, 2024
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primatesMatthew Gagne, Barbara J Flynn, Shayne F Andrew, et al.
Pageof 101